Chen Jiyun, Chen Ying, Huang Linglong, Lin Xiaofeng, Chen Hong, Xiang Wenwen, Liu Liang
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China.
Nat Biotechnol. 2025 Apr;43(4):558-568. doi: 10.1038/s41587-024-02255-7. Epub 2024 May 29.
Type V and type VI CRISPR-Cas systems have been shown to cleave nonspecific single-stranded DNA (ssDNA) or single-stranded RNA (ssRNA) in trans, but this has not been observed in type II CRISPR-Cas systems using single guide RNA. We show here that the type II CRISPR-Cas9 systems directed by CRISPR RNA and trans-activating CRISPR RNA dual RNAs show RuvC domain-dependent trans-cleavage activity for both ssDNA and ssRNA substrates. Cas9 possesses sequence preferences for trans-cleavage substrates, preferring to cleave T- or C-rich ssDNA substrates. We find that the trans-cleavage activity of Cas9 can be activated by target ssDNA, double-stranded DNA and ssRNA. The crystal structure of Cas9 in complex with guide RNA and target RNA provides a structural basis for the binding of target RNA to activate Cas9. Based on the trans-cleavage activity of Cas9 and nucleic acid amplification technology, we develop the nucleic acid detection platforms DNA-activated Cas9 detection and RNA-activated Cas9 detection, which are capable of detecting DNA and RNA samples with high sensitivity and specificity.
V型和VI型CRISPR-Cas系统已被证明可在反式作用中切割非特异性单链DNA(ssDNA)或单链RNA(ssRNA),但在使用单向导RNA的II型CRISPR-Cas系统中尚未观察到这种情况。我们在此表明,由CRISPR RNA和反式激活CRISPR RNA双链RNA引导的II型CRISPR-Cas9系统对ssDNA和ssRNA底物均表现出RuvC结构域依赖性的反式切割活性。Cas9对反式切割底物具有序列偏好,更倾向于切割富含T或C的ssDNA底物。我们发现,Cas9的反式切割活性可被靶标ssDNA、双链DNA和ssRNA激活。Cas9与向导RNA和靶标RNA复合物的晶体结构为靶标RNA结合激活Cas9提供了结构基础。基于Cas9的反式切割活性和核酸扩增技术,我们开发了核酸检测平台DNA激活的Cas9检测和RNA激活的Cas9检测,它们能够以高灵敏度和特异性检测DNA和RNA样本。
Nat Biotechnol. 2025-4
Nature. 2014-12-11
Angew Chem Int Ed Engl. 2021-11-2
Nucleic Acids Res. 2024-5-8
Synth Syst Biotechnol. 2025-7-21
Microorganisms. 2025-8-14
Res Sq. 2025-6-9
Nat Biomed Eng. 2025-6-20
Adv Sci (Weinh). 2025-8
Clin Transl Med. 2025-6
ACS Appl Bio Mater. 2025-5-19
Nucleic Acids Res. 2025-2-8
Nat Commun. 2023-9-5
Front Genome Ed. 2022-7-26
Nucleic Acids Res. 2022-6-24